An alpha-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes. Clinical and experimental medicine [Clin Exp Med] Journal article | | Title | An alpha-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes. | | Author(s) | Tsunosue M, Mashiko N, Ohta Y, Matsuo Y, Ueda K, Ninomiya M, Tanaka SI, Hoshiko M, Yoshiyama Y, Takeuchi M, Ueda SI, Yamagishi SI | | Institution | YY Research Group, Yanagawa-Yamato, Japan. | | Source | Clin Exp Med 2009 Oct 16. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19834782 |
|
|
| |
Advertise on this site.
| | |
|
